• Skip to main content
BC

biochimica clinica

en_US English
en_US English it_IT Italian
  • Home
  • Casi clinici
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • Archivio BC fino a 2024
  • Sottometti un articolo
  • Norme Autori
  • Cerca

CASI CLINICI – Case Reports

Volume:

Biochimica Clinica 2019; 43(3) e31-e35

Pubblicato on-line:

July 4, 2019

DOI:

DOI: 10.19186/BC_2019.054

Scarica in PDF:
Autenticazione richiesta

La ricerca degli anticorpi anti-nucleo non è sempre di facile interpretazione

AUTORI

Serena Silvestri1, Veronica Falciani2, Andrea Costantini2,3, Antonio Fortunato1
1Unità Operativa Complessa Patologia Clinica Azienda Sanitaria Unica Regionale Marche - Area Vasta 5, Ascoli Piceno
2Servizio Regionale di Immunologia Clinica e Tipizzazione Tessutale, Azienda Ospedali Riuniti di Ancona
3Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica delle Marche

ABSTRACT

Anti-nucleus antibodies detection is not always easy to interpret

Antinuclear antibodies (ANA) displaying densefine speckled pattern on HEp-2/HEp-2000 cells are frequently observed in clinical laboratory, often associated withanti-DFS70 antibodies. Anti-DFS70 positive patients rarely develop systemic autoimmune rheumatic disease,especially in the absence of clinical evidence or additional antibodies.
A 60-years old woman complaining severe muscle weakness of the legs was tested positive for dense fine speckledANA pattern by indirect immune-fluorescence. Immunoblot analysis revealed the presence of anti-DFS70 antibodies.Positivity for anti-dsDNA antibodies, not revealed by immunoblot, was also found by Crithidia luciliae(CL). All theresults were confirmed by a different laboratory.
This case underlines the complex interpretation of a laboratory scenario where anti-DFS70 possibly coexist with muchmore specific and clinically relevant ANA. The discrepancies (observed in both laboratories) between CL and theother methods is puzzling, and may be due to different reasons, including false positive CL results or interference.

BIBLIOGRAFIA

HOME
PRIVACY POLICY
5x1000 Docemus

LOGO SIBioC

EDITORE RESPONSABILE
Alberto Oliaro

EDITORIAL SECRETARY
Edizioni Minerva Medica S.p.A.
Corso Bramante 83-85, 10126 Torino
T +39 011 678282
journals.dept@minervamedica.it

Designed by Biomedia srl
© 2025 SIBioC
P. IVA IT 06484860967